|
|
Volumn 63, Issue 3, 2004, Pages 523-527
|
|
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANILIDE;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
BICALUTAMIDE;
CHROMOGRANIN;
CHROMOGRANIN A;
GONADORELIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTATE SPECIFIC ANTIGEN;
TRIPTORELIN;
TUMOR MARKER;
TUMOR PROTEIN;
ADENOCARCINOMA;
AGED;
ARTICLE;
BLOOD;
CELL DIFFERENTIATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG POTENTIATION;
HUMAN;
LYMPHADENECTOMY;
MALE;
METHODOLOGY;
MIDDLE AGED;
NEOPLASM;
NEUROSECRETION;
PATHOLOGY;
PROSTATE TUMOR;
PROSTATECTOMY;
RANDOMIZED CONTROLLED TRIAL;
ADENOCARCINOMA;
AGED;
ANDROGENS;
ANILIDES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTINEOPLASTIC AGENTS, HORMONAL;
CELL DIFFERENTIATION;
CHROMOGRANIN A;
CHROMOGRANINS;
DISEASE PROGRESSION;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
LYMPH NODE EXCISION;
MALE;
MIDDLE AGED;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
NEUROSECRETORY SYSTEMS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
TRIPTORELIN;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
|
EID: 2942694079
PISSN: None
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2003.10.043 Document Type: Article |
|
Times cited : (16)
|
|
References (0)
|
